Notably, multi-peptide PLK1122/Sur20DC_TriVax immunisation combining PD-L1 blockade exhibited significantly superior therapeutic anti-tumour effects, where complete tumour eradication was attained (one out of eight mice). The gene discussed is CD274; the disease is neoplasm.